ArticleOncogene2016

Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling.

E Sanchez-Lopez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.